A detailed history of Alpha Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpha Financial Partners, LLC holds 245 shares of LLY stock, worth $188,101. This represents 0.15% of its overall portfolio holdings.

Number of Shares
245
Previous 457 46.39%
Holding current value
$188,101
Previous $414 Million 47.59%
% of portfolio
0.15%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $163,693 - $203,524
-212 Reduced 46.39%
245 $217 Million
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $5,798 - $7,272
-8 Reduced 1.72%
457 $414 Million
Q4 2023

Jan 29, 2024

SELL
$525.19 - $619.13 $2,100 - $2,476
-4 Reduced 0.85%
465 $271 Million
Q3 2023

Nov 07, 2023

SELL
$434.7 - $599.3 $86,940 - $119,859
-200 Reduced 29.9%
469 $252 Million
Q4 2022

Feb 16, 2023

BUY
$321.55 - $374.67 $215,116 - $250,654
669 New
669 $245 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alpha Financial Partners, LLC Portfolio

Follow Alpha Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Financial Partners, LLC with notifications on news.